Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Clinical Subtype | Transcriptional Subtype | Small Molecule | Antibody | Perturbagen Target | Perturbagen Class | Perturbagen Concentration | Perturbagen Conc Unit | Biological Replicate ID | Relative Cell Count | Normalized Growth Rate Inhibition Value | Nominal Division Rate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 184A1 | NM | Basal | Mebendazole | 0.00427 | uM | 12684.174 | 1.0191 | 1.0260 | 1.4645 | |||
| 184A1 | NM | Basal | Mebendazole | 0.0213 | uM | 12684.174 | 0.9524 | 0.9345 | 1.4645 | |||
| 184A1 | NM | Basal | Mebendazole | 0.107 | uM | 12684.174 | 1.0228 | 1.0311 | 1.4645 | |||
| 184A1 | NM | Basal | Mebendazole | 0.533 | uM | 12684.174 | 0.7416 | 0.6307 | 1.4645 | |||
| 184A1 | NM | Basal | Mebendazole | 2.67 | uM | 12684.174 | 0.7334 | 0.6183 | 1.4645 | |||
| 184A1 | NM | Basal | Mebendazole | 13.3 | uM | 12684.174 | 0.7031 | 0.5723 | 1.4645 | |||
| 184A1 | NM | Basal | Mebendazole | 66.7 | uM | 12684.174 | 0.6777 | 0.5334 | 1.4645 | |||
| 184B5 | NM | Basal | Mebendazole | 0.000171 | uM | 12979.174 | 1.0497 | 1.0629 | 1.5680 | |||
| 184B5 | NM | Basal | Mebendazole | 0.000853 | uM | 12979.174 | 0.7887 | 0.7191 | 1.5680 | |||
| 184B5 | NM | Basal | Mebendazole | 0.00427 | uM | 12979.174 | 1.0135 | 1.0172 | 1.5680 | |||
| 184B5 | NM | Basal | Mebendazole | 0.0213 | uM | 12979.174 | 1.0242 | 1.0307 | 1.5680 | |||
| 184B5 | NM | Basal | Mebendazole | 0.107 | uM | 12979.174 | 1.0495 | 1.0626 | 1.5680 | |||
| 184B5 | NM | Basal | Mebendazole | 0.533 | uM | 12979.174 | 0.8469 | 0.7989 | 1.5680 | |||
| 184B5 | NM | Basal | Mebendazole | 2.67 | uM | 12979.174 | 0.7803 | 0.7073 | 1.5680 | |||
| 184B5 | NM | Basal | Mebendazole | 13.3 | uM | 12979.174 | 0.6596 | 0.5338 | 1.5680 | |||
| 184B5 | NM | Basal | Mebendazole | 66.7 | uM | 12979.174 | 0.7708 | 0.6941 | 1.5680 | |||
| 21MT-1 | HER2amp | - | Mebendazole | 0.000171 | uM | 13719.174 | 0.9527 | 0.8842 | 0.8124 | |||
| 21MT-1 | HER2amp | - | Mebendazole | 0.000853 | uM | 13719.174 | 0.9497 | 0.8770 | 0.8124 | |||
| 21MT-1 | HER2amp | - | Mebendazole | 0.00427 | uM | 13719.174 | 0.9573 | 0.8954 | 0.8124 | |||
| 21MT-1 | HER2amp | - | Mebendazole | 0.0213 | uM | 13719.174 | 0.9638 | 0.9113 | 0.8124 | |||
| 21MT-1 | HER2amp | - | Mebendazole | 0.107 | uM | 13719.174 | 0.9690 | 0.9241 | 0.8124 | |||
| 21MT-1 | HER2amp | - | Mebendazole | 0.533 | uM | 13719.174 | 0.9512 | 0.8804 | 0.8124 | |||
| 21MT-1 | HER2amp | - | Mebendazole | 2.67 | uM | 13719.174 | 0.9647 | 0.9134 | 0.8124 | |||
| 21MT-1 | HER2amp | - | Mebendazole | 13.3 | uM | 13719.174 | 0.9285 | 0.8255 | 0.8124 | |||
| 21MT-1 | HER2amp | - | Mebendazole | 66.7 | uM | 13719.174 | 0.6096 | 0.0875 | 0.8124 |